Anteris Technologies Global Corp. (AVR)
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.9M
- Net income
- -$94.1M
- Total assets
- $23.0M
- Market cap
- $938.4M
- Gross margin
- 70.3%
- Operating margin
- -4908.2%
- Net margin
- -4925.5%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $1.9M
- Cost of revenue
- $569.0K
- Gross profit
- $1.3M
- Operating expenses
- $95.2M
- Operating income
- -$93.9M
- Income tax
- $0
- Net income
- -$94.2M
- EPS (basic)
- $-2.55
- EPS (diluted)
- $-2.55
Balance sheet
- Total assets
- $23.0M
- Current assets
- $15.7M
- Total liabilities
- $23.2M
- Current liabilities
- $21.4M
- Shareholders’ equity
- -$253.0K
Cash flow
- Operating cash flow
- -$77.8M
- Investing cash flow
- -$596.0K
- Financing cash flow
- $20.6M
- Net cash flow
- -$57.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $938.4M
- EPS (diluted)
- $-2.55
- Shares outstanding
- 115.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 13, 2024
Anteris Technologies Global Corp. (AVR) Stock Price
- Reported a net loss of $94.1M in FY2025.
- Gross margin of 70.3%, net margin -4925.5%.
- Trading 23% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Anteris Technologies Global Corp..
Write a review
News about Anteris Technologies Global Corp.
News & sentiment via Polygon.io
Anteris Technologies Global Corp.: frequently asked questions
Is Anteris Technologies Global Corp. an American company?
Anteris Technologies Global Corp. is a US-based company headquartered in Eagan, Minnesota, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Anteris Technologies Global Corp. headquartered?
Anteris Technologies Global Corp. is headquartered in Eagan, Minnesota, United States.
Is Anteris Technologies Global Corp. publicly traded?
Yes — Anteris Technologies Global Corp. is a publicly traded company. Its stock trades under the ticker symbol AVR on the NASDAQ.
What does Anteris Technologies Global Corp. do?
Anteris Technologies Global Corp. is an American Medical Devices company in the Health & Beauty sector.
